University of Sussex
Browse

File(s) not publicly available

Does endocrine therapy for the treatment and prevention of breast cancer affect memory and cognition?

journal contribution
posted on 2023-06-07, 16:15 authored by Valerie JenkinsValerie Jenkins, Louise Atkins, Lesley FallowfieldLesley Fallowfield
Oestrogen receptors have been identified in several areas of the brain important in cognitive performance, including the prefrontal cortex (active during short-term working memory), the hippocampus and related cortical areas (learning and storage of information) and the amygdala (involved in the modulation of memory consolidation). There is much debate as to whether or not a reduction in oestrogen levels results in a corresponding decline in cognitive processing. Arguments for an effect are based on findings from laboratory and hormone replacement studies and the pharmacological actions of breast cancer drugs. However, there are few clinical data substantiating the claim that endocrine therapies used in the treatment and prevention of breast cancer could affect cognition. This paper examines the main evidence associated with this claim and discusses the importance of examining such issues within randomised trials.

History

Publication status

  • Published

Journal

European Journal of Cancer

ISSN

0959-8049

Publisher

Elsevier

Issue

9

Volume

43

Page range

1342-1347

Department affiliated with

  • Sussex Health Outcomes Research & Education in Cancer (SHORE-C) Publications

Full text available

  • No

Peer reviewed?

  • Yes

Legacy Posted Date

2012-01-04

Usage metrics

    University of Sussex (Publications)

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC